Cargando…

Low dose naltrexone in multiple sclerosis: Effects on medication use. A quasi-experimental study

Low dose naltrexone (LDN) has become a popular off-label therapy for multiple sclerosis (MS). A few small, randomized studies indicate that LDN may have beneficial effects in MS and other autoimmune diseases. If proven efficacious, it would be a cheap and safe alternative to the expensive treatments...

Descripción completa

Detalles Bibliográficos
Autores principales: Raknes, Guttorm, Småbrekke, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669439/
https://www.ncbi.nlm.nih.gov/pubmed/29099849
http://dx.doi.org/10.1371/journal.pone.0187423